FOLDERS
You are here: For the applicantsNews and eventsCoronavirusInternational news
Funding for vaccine development
08 April 2020
Modified: 08 April 2020
Reading time: 1 minute(s)
Share
ShareShare
Print
PrintPrint
On 16 March, the European Commission offered up to €80 million of financial support to CureVac, a highly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe.

On 16 March, the European Commission offered up to €80 million of financial support to CureVac, a highly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe. CureVac was previously the recipient of the EU's first inducement prize in 2014 for its innovative vaccine technology.

More information: https://ec.europa.eu/

Updated: 08 April 2020
Feedback
Was this page helpful?
Yes
No
None of relevance
On this webpage we use http cookies for providing safe browsing and the best user experience. In our Data Protection Information you can find further information about how we care about the protection of your data.
OK